ArticleJournal of Alzheimer's disease : JAD2020

Zibotentan, an Endothelin A Receptor Antagonist, Prevents Amyloid-β-Induced Hypertension and Maintains Cerebral Perfusion.

Jennifer C Palmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.